Roquefort Therapeutics Plc operates as an investment company. It was formed to acquire medical biotechnology businesses that are focused on early stage opportunities to include drug and vaccine development, diagnostics, immuno-therapy, and cell and gene therapies. The company was founded on August 17, 2020 and is headquartered in London, the United Kingdom.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Roquefort Therapeutics Plc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Roquefort Therapeutics Plc market cap is $3.36M.
What is the 52-week high for Roquefort Therapeutics Plc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Roquefort Therapeutics Plc 52 week high is $0.05 as of October 01, 2025.
What is the 52-week low for Roquefort Therapeutics Plc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Roquefort Therapeutics Plc 52 week low is $0.0214 as of October 01, 2025.
What is Roquefort Therapeutics Plc stock price today?
Roquefort Therapeutics Plc stock price today is $0.0214.
What was Roquefort Therapeutics Plc stock price yesterday?
Roquefort Therapeutics Plc stock price yesterday was $0.05.
What is the PE ratio of Roquefort Therapeutics Plc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Roquefort Therapeutics Plc’s P/E ratio is -2.25.
What is the Price-to-Book ratio of Roquefort Therapeutics Plc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Roquefort Therapeutics Plc P/B ratio is 0.4733.
What is the 50-day moving average of Roquefort Therapeutics Plc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Roquefort Therapeutics Plc 50-day moving average is $0.0214.